Horacio Herrera-Fajer

Head of Life Insurance Partnerships
GRAIL
Horacio Herrera-Fajer is an accomplished strategist specializing in driving clinical trial landscape, while developing lead generation across new channels. As part of the core team, he helped launch Galleri, the first ever multi-cancer early detection blood test. He serves as the Head of Life Insurance Partnerships by showcasing how offering Galleri can help stage shift cancer and with that help bend the mortality curve. Prior to joining Grail in 2020, he led corporate development at Science 37. His entrepreneurial mindset and natural curiosity have guided him to identify opportunities to close gaps and build company revenue. He holds a degree in Political Science and Government from Yale University. He is fluent in English, Spanish and some Chinese.

Sessions by Horacio Herrera-Fajer

03:45 PM - 04:20 PM
Life & Health Track: Islander C 

How the Life Insurance Industry is Embracing Innovation to Detect Cancer Early

What do Munich Re, a major global reinsurer, John Hancock, a life insurance carrier, and GRAIL, the makers of Galleri‚ď°, a multi-cancer early detection test have in common?  Saving lives by detecting cancer early when it can be cured.

Join us to hear from Marc Giguere, President & CEO, Munich Re Life US, Brooks Tingle, the CEO of John Hancock and Josh Ofman, President of Grail as they discuss how together, they are changing the trajectory of cancer mortality one policyholder at a time.

Learn how you can be on the cutting edge of innovation and technology.

Contact Us

Thank you for your interest in InsureTech Connect! We look forward to hearing from you. Contact us below with general inquiries.